Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing–Remitting Multiple Sclerosis Patients

Keyphrases

• Polymorphism 100%
• Disease Progression 100%
• Multiple Sclerosis Treatment 100%
• Multiple Sclerosis 100%
• Dopaminergic Receptors 100%
• Multiple Sclerosis Progression 75%
• Single nucleotide Polymorphism 50%
• Receptor Gene 50%
• Dopamine 25%
• Personalized Approach 25%
• GC Genotype 25%
• Nervous System Diseases 25%
• Pathophysiological Mechanisms 25%
• Immune Function 25%
• Evidence Support 25%
• Novel Therapeutics 25%
• Caregivers 25%
• Overall Well-being 25%
• Caucasian Patients 25%
• Multiple Sclerosis Severity Score 25%
• Multiple Sclerosis Disability 25%
• Functional Single nucleotide Polymorphism 25%
• Chronic Autoimmune Diseases 25%
• DRD3 25%
• Heterozygous Genotype 25%

Neuroscience

• Multiple Sclerosis 100%
• Dopamine Receptor 100%
• Single-Nucleotide Polymorphism 27%
• Receptor Gene 18%
• Central Nervous System 9%
• Autoimmune Disease 9%
• Treatment of Multiple Sclerosis 9%